Search results for "Coronary Heart Disease"

showing 10 items of 116 documents

Diagnose eines intramyokardialen Hämatoms nach traumatischem Myokardinfarkt durch Magnetresonanztomographie

1999

Thoraxverletzungen treten bei etwa 30% aller traumatisierten Patienten auf, wobei in den meisten Fallen Verkehrsunfalle die Ursache sind. Wir berichten uber den Fall eines Patienten, der nach einem Skiunfall einen traumatischen Vorderwandinfarkt erlitt. Im weiteren Verlauf kam es zu einer ausgedehnten intramyokardialen Einblutung. Differentialdiagnostisch kam zunachst ein linksventrikulares Pseudo- bzw. Pseudopseudoaneurysma in Frage, kernspintomographisch konnte jedoch durch den Nachweis eines schmalen Myokardsaums sowohl ventral als auch dorsal der Raumforderung die Diagnose eines intramyokardialen Hamatoms gestellt werden. Bei dem Patienten wurde daraufhin eine aortokoronare Bypass-Opera…

Gynecologymedicine.medical_specialtybusiness.industryDiagnostico diferencialmedicineMyocardial diseaseCardiology and Cardiovascular MedicinebusinessCoronary heart diseaseZeitschrift f�r Kardiologie
researchProduct

Asociación de factores lipídicos, genotipo de APOE y tipos de mutación del gen del receptor de LDL con el infarto agudo de miocardio en sujetos con h…

2002

Fundamento Evaluar la relacion de los lipidos, del genotipo de APOE y del tipo de mutacion delgen del receptor de LDL, clasificandolas en nulas y no nulas, sobre la prevalencia de infartoagudo de miocardio (IAM) en individuos heterocigotos con hipercolesterolemia familiar (HF) delsur de Europa, donde existen pocos datos al respecto. Pacientes y metodo Se trata de un estudio transversal que compara individuos con HF e IAM(n = 32) y a individuos con HF sin IAM (n = 76) mayores de 35 anos (41 varones y 67 mujeres).En 88 sujetos se establecio el diagnostico genetico, siendo divididos en portadores de mutacionesnulas o no nulas del gen del receptor de LDL. Se han comparado los factores clasicosd…

Gynecologymedicine.medical_specialtybusiness.industryMedicineGeneral MedicinebusinessCoronary heart diseaseMedicina Clínica
researchProduct

Primär-Dilatation versus Thrombolyse bei Patienten mit akutem Myokardinfarkt, die nicht in randomisierte Studien eingeschlossen wurden

1999

Die randomisierten Studien zum Vergleich der Thrombolyse und der Primar-Dilatation beim akuten Myokardinfarkt schlossen keine Patienten mit Linksschenkelblock, nichtdiagnostischem ersten Elektrokardiogramm, einer Prahospitalzeit von ≥ 12 h oder einer unbekannten Prahospitalzeit ein. Im klinischen Alltag werden jedoch haufig solche Patienten mittels Thrombolyse oder Primar-Dilatation behandelt. Um diese Patientengruppen zu beschreiben und den Einflus der Lyse und der Primar-Dilatation zu vergleichen, untersuchten wir die Daten aus der “Maximale Individuelle Optimierte Therapie beim Akuten Myokardinfarkt” (MITRA)-Studie. Bei 737 von 3308 (22,3 %) mittels Primar-Dilatation oder Lyse behandelte…

Gynecologymedicine.medical_specialtybusiness.industrymedicineMyocardial diseaseCardiology and Cardiovascular MedicinebusinessCoronary heart diseaseZeitschrift f�r Kardiologie
researchProduct

Die akute Gefäßperforation mit Shuntbildung in den rechten Ventrikel nach perkutaner transluminaler Koronarangioplastie. Kernspintomographischer und …

1998

Die Gefasperforation nach transluminaler Koronarangioplastie (PTCA) stellt eine seltene Komplikation dieser etablierten Behandlungsmethode dar. Die Therapie wird bestimmt durch die hamodynamische Beeintrachtigung des linken oder rechten Ventrikels. Wir berichten uber den Fall einer Gefasperforation nach PTCA mit Shuntbildung von der rechten Koronararterie in den rechten Ventrikel, wobei der Shuntflus sowohl kernspintomographisch als auch dopplersonographisch dargestellt werden konnte.

Gynecologymedicine.medical_specialtybusiness.industrymedicineVentriculo derechoCardiology and Cardiovascular MedicinebusinessCoronary heart diseaseZeitschrift f�r Kardiologie
researchProduct

Lungenembolie: Weniger Rezidive durch längere orale Antikoagulation

2015

Bei Patienten mit einer Lungenembolie reduziert eine Antikoagulation uber 3–6 Monate das Rezidivrisiko. Unklar ist bislang, ob dieser Effekt auch nach dem Ende der Therapie erhalten bleibt. Aktuell wurde der Nutzen einer zusatzlichen Behandlung mit Warfarin uber 18 Monate nach einer initalen 6-monatigen Therapie mit Vitamin-K-Antagonisten untersucht.

Gynecologymedicine.medical_specialtybusiness.industrymedicineWarfarinGeneral Medicinemedicine.diseasebusinessVenous thromboembolismCoronary heart diseasePulmonary embolismmedicine.drugDMW - Deutsche Medizinische Wochenschrift
researchProduct

Cardiovascular risk in patients without known cardiovascular disease.

2014

Understanding the risks of atherosclerotic cardiovascular disease (CVD) allows for better patient education and management. Multiple risk models have been validated in large patient populations and provide insights into the risks associated with CVD. When assessing such risks, we suggest using a model that predicts myocardial infarction, cardiovascular death, and/or cerebrovascular events. In this review, we analyze several risk models and stratify the risks associated with CVD. We suggest that appropriate profiling of patients at-risk of CVD will lead to better physician recognition and treatment of modifiable risk factors, appropriate application of ATP III treatment for hyperlipidemia, a…

Health Knowledge Attitudes PracticeRisk FactorModels TheoreticalCoronary heart diseaseMyocardial infarctionPatient Education as TopicCardiovascular DiseasesRisk FactorsCardiovascular DiseasePractice Guidelines as TopicBorderline risk factorHumansC Reactive ProteinCardiovascular multiple risk factorHumanEuropean review for medical and pharmacological sciences
researchProduct

Psychodynamic Motivation and Training program (PMT) for the secondary prevention in patients with stable coronary heart disease: study protocol for a…

2013

Background Nonpharmacological secondary prevention of coronary heart disease is considered a safe and effective measure to substantially reduce mortality. Despite the effectiveness of lifestyle changes, the compliance rate of patients is very low mainly due to psychosocial barriers. Psychotherapeutic approaches that address how persons think about themselves and their behaviors appear to have a significant potential for improving health behavior. Methods/design Against this background, our study aims to examine the feasibility and effects of a Psychodynamic Motivation and Training program (PMT) as compared to one session of advice in exercise training (EX) and treatment as usual (TAU). For …

Health Knowledge Attitudes PracticeTime FactorsHealth BehaviorCoronary DiseaseStudy ProtocolCognitionSpiroergometryGermanySecondary PreventionHumansMotivationExercise ToleranceHome based exercise trainingPhysical activityRecovery of FunctionPsychodynamic psychotherapyExercise TherapyCoronary heart diseaseTreatment OutcomeResearch DesignQuality of LifeFeasibility StudiesPatient ComplianceEndothelium VascularPsychotherapy PsychodynamicRisk Reduction BehaviorBiomarkersTrials
researchProduct

LDL apheresis in a homozygous familial hypercholesterolemic child aged 4.5.

1997

Preliminary experience with the efficacy and safety of dextran sulfate cellulose low-density lipoprotein (LDL) apheresis for the treatment of a 4.5-year-old girl with homozygous familial hypercholesterolemia and coronary artery disease is reported. The decrease of the most atherogenic apolipoprotein B-containing lipoproteins, low-density lipoprotein (LDL) and lipoprotein(a) (Lp [a]), were in the ranges of 63.1-68.7%, and 52.5-58.6%, respectively. The child tolerated LDL apheresis without any clinically significant complications. Therefore, she was submitted to a long-term program of treatment at intervals of 15 days. The experience suggests the possibility of an early beginning of extracorp…

Homozygous Familial Hypercholesterolemiamedicine.medical_specialtyApolipoprotein BBiomedical EngineeringMedicine (miscellaneous)BioengineeringCoronary Disease4.5 years-old girlFamilial hypercholesterolemiaBiomaterialsHyperlipoproteinemia Type IIchemistry.chemical_compoundInternal medicinemedicineCoronary Heart DiseaseHumansHyperlipoproteinemia Type IIbiologybusiness.industryCholesterolHomozygoteGeneral MedicineLipoprotein(a)Low Density Lipoprotein (LDL) apheresis; 4.5 years-old girl; Homozygous Familial Hypercholesterolemia; Coronary Heart Diseasemedicine.diseaseLipoproteins LDLApheresisEndocrinologyCholesterolLow Density Lipoprotein (LDL) apheresischemistryLDL apheresisChild Preschoolbiology.proteinBlood Component Removallipids (amino acids peptides and proteins)FemalebusinessLipoproteinLipoprotein(a)Artificial organs
researchProduct

Evaluation of the Haemorheological Determinants in Coronary Heart Disease

1984

Increased blood viscosity has been described in patients with coronary artery disease (1, 2, 3, 4, 5, 6, 7, 8).

Increased blood viscosityCoronary artery diseasemedicine.medical_specialtybusiness.industryInternal medicineBlood viscosityCardiologyMedicineIn patientMyocardial infarctionbusinessmedicine.diseaseCoronary heart disease
researchProduct

What is new for an old molecule? : Systematic review and recommendations on the use of resveratrol

2011

BackgroundResveratrol is a natural compound suggested to have beneficial health effects. However, people are consuming resveratrol for this reason without having the adequate scientific evidence for its effects in humans. Therefore, scientific valid recommendations concerning the human intake of resveratrol based on available published scientific data are necessary. Such recommendations were formulated after the Resveratrol 2010 conference, held in September 2010 in Helsingør, Denmark.MethodologyLiterature search in databases as PUBMED and ISI Web of Science in combination with manual search was used to answer the following five questions: (1)Can resveratrol be recommended in the prevention…

Isi web of sciencePhytochemistrymedicine.medical_specialtySystematic ReviewsNon-Clinical Medicineendocrine system diseasesClinical Research DesignScience PolicyPhytopharmacologyScienceMEDLINEPharmacologyResveratrolCardiovascularScientific evidenceAnimal datachemistry.chemical_compoundEndocrinologyComplementary and Alternative MedicineStilbenesmedicineHumansObesityIntensive care medicineNutritionDiabetic EndocrinologyTreatment GuidelinesHealth Care PolicyMultidisciplinaryCancer preventionbusiness.industryorganic chemicalsQRfood and beveragesResearch AssessmentCoronary heart diseaseClinical trialChemistryOncologychemistryResveratrolMedicinePublic HealthPreventive MedicinebusinessCancer Preventionhormones hormone substitutes and hormone antagonistsResearch Article
researchProduct